Upcoming Events
Log In
Pricing
Free Trial

CAD-RADS

HIDE
PrevNext

0:00

And this next video. I'd like to take a minute to talk about CAD rats.

0:04

What is CAD rats catarads is

0:07

one of these scoring systems that follows in

0:10

the tradition of other RADS types systems such as

0:13

bi-rads and Pirates. It's developed.

0:16

Of course by consensus of

0:19

multiple societies including

0:22

the American College of radiology American College

0:25

of Cardiology and some other societies

0:29

and basically it has been created to

0:32

develop a standardized method for reporting coronary

0:35

CT findings. It has been adopted by

0:38

many practices and it was originally published in 2016

0:41

and more recently updated just in 2022 up

0:44

to catarad's version 2.02 modification

0:48

added a couple things overall

0:51

plaque extent term called P1

0:54

through P4, which we'll talk about and then also an ischemia

0:57

modifier to reflect the development of we'll see

1:00

of fractional flow Reserve techniques that I'll talk

1:03

about as well. So just in general, you know,

1:06

should you use CAD RADS? I can't really answer that

1:09

question for you. I think it is helpful as

1:12

a standardized way of reporting and certainly if

1:15

you have multiple Radiologists reading that read things slightly

1:18

different way. It's a good way to achieve consistency across your

1:21

site. Do you have to use catarads? I

1:24

would say no.

1:25

there are some cardiologists out there who have worked

1:28

with who don't like catarads as much because of not

1:31

so much the disease categories, but rather the

1:34

recommendations for treatment that go with

1:37

them. Honestly, it probably comes down to a discussion with

1:40

you and your referring clinicians as to what what do you

1:43

think?

1:43

Is the best moving forward certainly?

1:46

Just using the catarads or a catarad's style.

1:49

Sort of reporting to lump patients into specific

1:52

categories is definitely useful for standardizing

1:55

the reporting across here your site

1:58

no matter how you do it.

2:00

So let's talk about the catarad score and basically

2:03

you're scoring the the patient 0 to

2:06

5. And this is the score based on the most severe stenosis

2:09

in the patient. So it's a per patient

2:12

score and the scores range from 0 no

2:15

disease.

2:16

One and two which are in the non obstructive minimal

2:19

and Mild disease categories. Then there's moderate disease

2:22

that gray area that we talked about in the last video on 50

2:25

to 69% stenosis.

2:27

And then severe disease which has two subheadings and

2:30

this is important. There's the 70% or

2:33

greater in one or two vessels which would be 4A or

2:36

4B which would be three vessels

2:39

70% or greater.

2:41

Or left main over 50% and why is

2:44

that a distinction that's made the main reason here is that patients

2:47

who are in the floor be category are actually

2:50

patients who may be best managed by

2:53

cabbage. And so those patients it may

2:56

be kind of a do not pass go situation where they need to go see the

2:59

surgeon and be evaluated or at least

3:02

get a cath to confirm these findings and then

3:05

be evaluated for potential surgery patients with

3:08

one to two severe stenoses the

3:11

management. There is a little Mercure

3:14

And it's really keeps evolving over time in the

3:17

past. I think the thought would have been that anybody with a severe

3:20

stenosis should really be evaluated for potential stenting and

3:23

revascularization. However, more recent

3:26

trials have shown that that may not be actually

3:29

needed in a lot of patience and medical therapy has

3:32

really shown to be just as successful in these

3:35

patients at least in improving mortality

3:38

and other nature cardiovascular outcomes

3:41

like a subsequent Mi heart attack

3:44

for instance and then cataracts five that's an inclusion

3:47

and non-diagnostic study.

3:50

So there are also other pieces to the cadread Schooler.

3:53

So you get a catarad score. Plus these other letters

3:56

that follow and the new one is

3:59

the plaque burden which is graded from

4:02

one to four one being mild to

4:05

being moderate three severe and for extensive they've actually

4:08

given us different ways to define the plaque

4:11

burden you can use a visual assessment. You can

4:14

do it from calcium score or you can

4:17

use this segmental involvement score. So the

4:20

calcium score you just look at the chart and whatever range your

4:23

calcium score falls into that's the number you give the patient P

4:26

1 through 4, so that's pretty simple.

4:29

The sis is the segmental involvement score. So

4:32

basically each coronary artery vessel segment

4:35

gets a score of 1 if they're involved with

4:38

any plaque of any kind. So a score

4:41

of three to four would mean that you may have the proximal and

4:44

mid LED and the proximal and mid-rca and

4:47

in that case you've got a score for

4:49

so it's actually doesn't take long to get you up to the severe level in

4:52

a lot of the patients that we see and then finally the

4:55

visual score they give you some information here about how to visually score

4:58

it. But basically it's a subjective assessment but

5:02

You know moderate amount would be one two vessels moderate out or

5:05

three with miles. So what is mild?

5:08

Meanwhile I'd say probably just one segment involved with vessel and

5:11

then it goes up from there.

5:13

What are the segments that we're talking about? Well, the coronary

5:16

artery segments have been defined by the Society of

5:19

cardiovascular CT and they have this guideline which

5:22

is widely available and they talk about the different segments

5:25

the corner arteries and basically you

5:28

have the left main is a segment approximal LED

5:31

is a segment middle. LED is a segment digital LEDs a

5:34

segment.

5:35

RCA proximal mid distal PDA,

5:38

you know, that's a segment the circumflex

5:41

proximal.

5:42

And then actually they lumped mid distal

5:45

into one segment for the circumflex and then each of

5:48

the major diagonal branches and obtuse marginal branches. And if you

5:51

have a ramus those are all segments as well. So basically, you know,

5:54

like I said, it doesn't take long to add up to quite a few segments with plaque When

5:57

you're counting up plaque severity.

5:59

Another thing that shows up in the cad

6:02

rats are these high-risk features and

6:05

Upstate? These are a bit controversial in terms

6:08

of it's not clearly known what to do with this high risk

6:11

plaque feature information and how it should affect management and that

6:14

that work is still being done. Some of this cadrad's information

6:17

is information that's going to be used to really

6:20

fuel future studies. That'll help us figure out how best

6:23

to use this information. But the idea behind these

6:26

high risk plaque features is that

6:28

There have been a lot of studies done where they take a look at patients who

6:31

end up having an acute coronary syndrome and

6:34

then they go back in time and look at what their coronary CT

6:37

was before they had this acute coronary syndrome. And when

6:40

you look at these patients, you'll find that these

6:43

particular features shown are more common in the

6:46

patients who end up going to acute coronary syndrome the problem

6:49

with the high risk plaque features. Unfortunately is that they're not very

6:52

specific you see these features and a lot

6:55

of patients and the vast majority of them will not go on to have acute coronary

6:58

syndrome. So that's where the question of how these will really

7:01

play into the patient management is still kind of a

7:04

little bit up in the air but hopefully more to come so as

7:07

we go through the different cases of

7:10

this course, I'm going to point out these features as we come across them.

7:13

But here's a review of the four features that are included

7:16

in the catarads.

7:18

So first, it's called spotty calcification and the idea

7:21

here is that you have a non calcified plaque, which

7:24

is this kind of lens shaped thing here and then within that

7:27

non calcified plaque, you've got a DOT of calcium in the

7:30

middle. That's spotty calcification.

7:33

Positive remodeling we talked about that already in the last

7:36

video. That's when the diameter of your vessel is

7:39

larger than the nearest normal segment because

7:42

the vessel has expanded to accommodate the plaque. And the

7:45

number here we think about is 1.1 a ratio of

7:48

1.1 of the level of the plaque compared to the normal

7:51

segment the napkin ring sign. This is honestly,

7:54

I think probably one of the tougher ones to see this and the low

7:57

attenuation plaque. This is actually when you look at a plaque

8:00

You see that you've got a low attenuation sort of

8:03

core of the plaque. Here's the Lumen. So

8:06

you've got this big non calcified plaque here. There's a low

8:09

attenuation area and surrounding that low attenuation area is

8:12

a brighter area, which is thought to be

8:15

an area of kind of enhancement of the rim of this plaque called

8:18

the napkin ring sign.

8:21

And then finally low attenuation plaque. That's a little more simple. That's where you get

8:24

non-calify plaque actually measures less than 30 ounce foot units these

8:27

two I would say are much more

8:30

rare to find. You know, when your day-to-day coronary

8:33

CT reading, whereas the top two, I'd say

8:36

are quite common when you're reading coronary c teams.

8:39

Other modifiers that are mentioned Within part of the catarad system

8:42

are listed here and you really would have

8:45

to refer to the whole cadres document to get all the

8:48

details. But basically there's also an addition

8:51

to non-diagnostic and high-risk black features we have ischemia

8:54

and that's to serve a yes/no stents. So

8:57

if you have a stent then you want to

9:00

you know mention that

9:01

Graft, let's say you have cabbage crafts.

9:04

Then your score should reflect the

9:07

patency of the graphed and the downstream

9:10

vessel beyond the graph the nestenosis your

9:13

score ignores any disease in the

9:16

native vessel, that's Upstream to the graph. So for instance, let's say

9:19

you have a LED occlusion. That's then

9:22

bypassed. You're not going to score the patient as a

9:25

you know, catarads five total occlusion. You're

9:28

gonna score them instead based on the patency

9:31

of the graph itself.

9:33

And then e is any sort of important coronary

9:36

findings that are not related to atherosclerosis such

9:39

as dissection aneurysmasculitis or something else along

9:42

those lines.

9:43

Just a quick note about ischemia and fractional

9:46

flow Reserve so ffr is something

9:49

that's come on to the scene in the past several years and as

9:52

generate a lot of excitement and the

9:55

idea here is that you take the anatomic information

9:58

about the coronaries and you

10:01

basically have these fancy computers with

10:04

high level processing power that segment out

10:07

the coronaries and based on the shape of the coronaries themselves.

10:10

They can actually calculate using these

10:13

computational fluid Dynamic approaches the

10:16

estimated flow across

10:19

the vessel in the various locations based on

10:22

the anatomy.

10:24

And it turns out that this actually holds up really well compared to

10:27

the gold standard which is actually sticking it down a catheter

10:30

in the patient and measuring the flow. And why

10:33

do we care about the flow? Well, the main reason we

10:36

care about the flow is that

10:37

We're interested in.

10:39

Whether or not there's a drop in flow across

10:42

the stenosis and the way that's measured by the

10:45

gold standard is this thing called the fractional flow reserve and

10:48

basically it's a ratio of the flow before and after

10:51

this stenosis and it tells us whether or not

10:54

there's a pressure drop across the stenosis.

10:57

And the amount of pressure drop that's important is a

11:00

pressure drop of 25% or greater.

11:03

So if your ffr is 0.75 that

11:06

means that you've had a 25% pressure drop that means

11:09

that you have a significance stenosis.

11:11

If your pressure drop is less than that if

11:14

it's less than 20% and that's consider not obstructive and

11:17

then there's this gray Zone which is somewhere between 25

11:20

and 20% pressure drop which is

11:23

considered indeterminate. So right now there is

11:26

a FDA approved third party vendor, which can do

11:29

this for you the way they have set up their system is

11:32

that you'll send out your coronary CT to their lab for processing and

11:35

then they'll send you back. The information afterwards folks are using

11:38

this basically to assess patients with

11:41

moderate disease and try to determine whether that moderate

11:44

disease is functionally significant or not. And sometimes

11:47

it can be surprising a plaque that looks really

11:50

severe on coronary CT on ffr analysis

11:53

may not be quite as severe. So it helps

11:56

guide and management and actually helps even more with

11:59

selecting patients who may need to go on to cardiac catheterization

12:02

and intervention and avoiding interventions

12:05

that aren't needed on patients who actually have ffr

12:08

which isn't in the obstructive.

12:12

Okay, and then my last slide on catarads is

12:16

just about the practice guidelines themselves and management

12:19

considerations that they

12:22

have Incorporated. So.

12:23

This is information within cataracts

12:26

says okay, if you have a catarads of you know, four what do

12:29

you do with the patient and it's a very busy slide

12:32

but basically the main thing you do and all these categories based

12:35

on some of the recent trial data is risk

12:38

factor modification and preventive pharmacotherapy. So

12:41

Optical medical management is in general recommended for

12:44

all these cases. Now, if you get into more severe

12:47

disease, you can consider catheterization and

12:51

revascularization if the symptoms persist after directed care

12:55

which in this case is usually medical management.

12:57

That's for those modern disease patients.

13:01

And then for those patients with severe disease.

13:03

Again, you want to do Optical medical management

13:06

and then consider other therapies

13:09

and revascularization per guidelines and the

13:12

guidelines, which is down here.

13:14

Would suggest that you could do some additional

13:17

Imaging or invasive coronary angiography.

13:20

If they're persistent symptoms, despite adequate medical

13:23

therapy. So a lot of this is getting back to

13:26

the fact that you know more recent trials have shown that

13:29

If you have a patient who has severe stenosis

13:32

that patient may not necessarily need to have

13:35

those stenosis opened up and revascularized that

13:38

Optical medical therapy can be just as effective

13:41

in a lot of those patients.

13:43

The one exception to that would be if patients have

13:46

severe Angel symptoms.

13:49

And that they don't improve with medical therapy. Then it is

13:52

recommended to go ahead and open up the stenosis and

13:55

revasclass those patients. So this is all within

13:58

the cataracts document and so it certainly

14:01

not expected that you remember any of this but just something to know

14:04

of as the next steps and what cadrads recommends

14:07

for our patients if we're using this

14:10

That sums up our cadrad's evaluation and

14:13

the next cases. We're going to move on to some real patient cases.

Report

Faculty

Stefan Loy Zimmerman, MD

Associate Professor of Radiology and Radiological Science

Johns Hopkins Medicine Department of Radiology and Radiological Science

Tags

Vascular

Cardiac

CT

Acquired/Developmental